Table III.
Perioperative outcomes of patients undergoing urgent/emergent patients in March-April 2020 and 2019
Variable | 2020: 116 patients | 2019: 34 patients | P |
---|---|---|---|
Type of intervention | |||
Open | 77 (66.4%) | 23 (67.6%) | 0.890 |
Endovascular | 28 (24.1%) | 6 (17.6%) | 0.427 |
Hybrid | 7 (6.0%) | 5 (14.7%) | 0.101 |
Angiography and medical therapy | 4 (3.4%) | 0 (0%) | 0.272 |
Setting | |||
Urgent (<48h) | 74 (63.8%) | 24 (70.6%) | 0.464 |
Emergent | 42 (36.2%) | 10 (29.4%) | 0.464 |
Procedural time (min) | 74 (IQR 49–130) | 75 (IQR 50–150) | 0.642 |
Intraoperative death | 0 (0%) | 0 (0%) | 0.997 |
Reintervention | 7 (6.0%) | 5 (14.7%) | 0.128 |
Clinical success | |||
Primary | 101 (87.1%) | 29 (85.3%) | 0.789 |
Secondary | 111 (95.7%) | 31 (91.2%) | 0.196 |
Adverse eventsa | |||
In-hospital death | 3 (2.6%) | 4 (11.8%) | 0.026 |
Major cardiac | 4 (3.4%) | 3 (8.8%) | 0.224 |
Major pulmonary | 5 (4.3%) | 3 (8.8%) | 0.341 |
Major renal | 5 (4.3%) | 3 (8.8%) | 0.355 |
Major cerebrovascular | 2 (1.7%) | 2 (5.9%) | 0.208 |
Bowel ischemia | 1 (0.8%) | 1 (2.9%) | 0.071 |
Amputation | 2 (1.7%) | 1 (2.9%) | 0.351 |
Spinal cord injury | 2 (1.7%) | 1 (2.9%) | 0.380 |
Perioperative bleeding requiring transfusion | |||
<3 RBC units | 15 (12.9%) | 10 (37%) | 0.098 |
≥3 RBC units | 11 (9.5%) | 2 (7.4%) | 0.302 |
Length of stay (days) | 4 (IQR 3–6) | 6 (IQR 2–10) | 0.635 |
RBC, red blood cells. Bold indicates the results reaching statistical significance (P < .05).
Major events are described as graded ≥2 according to reporting standards.